Ty Gluckman, MD: Improving Communication Post-Pandemic

Video

Phone communication may have decreased in recent years among doctors.

Because so many diseases impact different systems in the body, communication between specialists is paramount.

For example, when a patient presents with chronic kidney disease, then a cardiologist, nephrologist, and endocrinologist should be consulted.

But there are challenges and times when communication can fall through the wayside.

In an interview with HCPLive® during Pri-Med West 2022 in Anaheim, Ty Gluckman, MD, Medical Director of the Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), spoke about the importance of communication between specialists and where there is room to grew.

“I think there’s always an opportunity for improvement,” Gluckman said. “I would say too often there is siloing of care.”

One of the ways communication has changed over the years is in past years doctors would more frequently talk in person or at least over the phone. However, that type of communication has been replaced by note updates in the electronic medical record system, which is another challenge for many.

Gluckman also talked about how important it is to bring specialists and primary care doctors together for a conference to speak about several different aspects of medical care.

In fact, the three-day conference agenda featured sessions about pain, rheumatology, cardiology, psychiatry, gastroenterology, and more.

Gluckman is part of the advisory board organizing the meeting.

Related Videos
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
Lenard A. Adler, MD: “Symptoms of ADHD Need to Go Back to Childhood”
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Video 4 - "Innovations in Small Interfering RNA (siRNA) Therapy"
Video 3 - "Ongoing Lp(a) Trials and Clinical Approaches to Treatment"
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
© 2024 MJH Life Sciences

All rights reserved.